Xtrackers - MSCI Europe UCITS ETF (SWX: XEOU)
Switzerland
· Delayed Price · Currency is CHF · Price in USD| Assets | 251.55M |
| Expense Ratio | 0.30% |
| PE Ratio | 14.83 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +17.23% |
| Volume | 105 |
| Open | 17.39 |
| Previous Close | 17.33 |
| Day's Range | 17.33 - 17.39 |
| 52-Week Low | 14.53 |
| 52-Week High | 17.52 |
| Beta | n/a |
| Holdings | 415 |
| Inception Date | Feb 27, 2015 |
About XEOU
Xtrackers - MSCI Europe UCITS ETF is an exchange traded fund launched by Deutsche Asset & Wealth Management Investment S.A. The fund is managed by State Street Global Advisors Limited. It invests in the public equity markets of developed countries in Europe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of large-cap and mid-cap companies. The fund seeks to replicate the performance of the MSCI Total Return Net Europe Index, by investing in the stocks of companies as per their weightings in the index. It was formerly known as db x-trackers - MSCI Europe Index UCITS ETF (DR). Xtrackers - MSCI Europe UCITS ETF was formed on January 10, 2007 and is domiciled in Luxembourg.
Performance
XEOU had a total return of 17.23% in the past year. Since the fund's inception, the average annual return has been 7.98%, including dividends.
Top 10 Holdings
23.26% of assets| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk A/S | NOVO.B | 3.89% |
| ASML Holding N.V. | ASML | 3.17% |
| Nestle SA | NESN.SW | 2.50% |
| AstraZeneca PLC | AZN | 2.36% |
| Novartis AG Registered Shares | NOVN.SW | 2.06% |
| Roche Holding AG | ROG.SW | 2.06% |
| SAP SE | SAP | 2.00% |
| Shell plc | SHEL | 1.99% |
| LVMH Moët Hennessy - Louis Vuitton, Société Européenne | MC | 1.80% |
| HSBC Holdings plc | HSBA | 1.43% |